Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular condition. It is the leading cause of sudden ...

Hypertrophic cardiomyopathy (HCM) was first described in the late 1950s as a disease typified by substantial thickening of the myocardium, particularly the left ventricular wall, with no overt cause.

Cardiovascular magnetic resonance imaging (CMRI) has emerged as an important imaging modality for the diagnosis, management and risk stratification of patients with hypertrophic cardiomyopathy (HCM).

Cardiac MRI has a significant role in establishing the diagnosis of HCM. In the three principal management issues related to HCM; testing of family members of affected individuals; assessing the ...